Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 18 studies | 41% ± 13% | |
| ependymal cell | 3 studies | 49% ± 10% |
Insufficient scRNA-seq data for expression of MAP3K19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 92% | 226.48 | 530 / 578 | 12% | 0.45 | 138 / 1155 |
| brain | 76% | 105.01 | 2013 / 2642 | 16% | 0.95 | 110 / 705 |
| spleen | 76% | 9.42 | 183 / 241 | 0% | 0 | 0 / 0 |
| prostate | 60% | 12.40 | 146 / 245 | 4% | 0.11 | 22 / 502 |
| adrenal gland | 51% | 4.26 | 131 / 258 | 0% | 0 | 0 / 230 |
| breast | 43% | 4.26 | 198 / 459 | 5% | 0.16 | 55 / 1118 |
| intestine | 47% | 4.82 | 455 / 966 | 1% | 0.02 | 3 / 527 |
| liver | 47% | 3.72 | 106 / 226 | 0% | 0.00 | 1 / 406 |
| uterus | 39% | 49.03 | 67 / 170 | 5% | 0.32 | 22 / 459 |
| bladder | 43% | 2.95 | 9 / 21 | 1% | 0.02 | 4 / 504 |
| adipose | 39% | 3.50 | 474 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 38% | 4.42 | 34 / 89 | 0% | 0.02 | 4 / 901 |
| skin | 37% | 3.30 | 666 / 1809 | 0% | 0.00 | 1 / 472 |
| ovary | 26% | 3.94 | 46 / 180 | 10% | 0.35 | 43 / 430 |
| muscle | 35% | 3.18 | 284 / 803 | 0% | 0 | 0 / 0 |
| stomach | 30% | 2.37 | 108 / 359 | 2% | 0.03 | 6 / 286 |
| thymus | 30% | 3.36 | 198 / 653 | 0% | 0 | 0 / 605 |
| esophagus | 26% | 2.12 | 369 / 1445 | 2% | 0.05 | 3 / 183 |
| blood vessel | 22% | 1.68 | 292 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 17% | 1.15 | 57 / 328 | 3% | 0.10 | 5 / 178 |
| peripheral blood | 14% | 1.69 | 134 / 929 | 0% | 0 | 0 / 0 |
| heart | 11% | 0.77 | 96 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0004674 | Molecular function | protein serine/threonine kinase activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | MAP3K19 |
| Protein name | Mitogen-activated protein kinase kinase kinase 19 (EC 2.7.11.1) (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4) Mitogen-activated protein kinase kinase kinase 19 |
| Synonyms | RCK YSK4 |
| Description | |
| Accessions | ENST00000392917.8 [Q56UN5-7] A0A590UJV9 H7C041 Q56UN5 ENST00000414343.1 ENST00000437365.2 ENST00000392918.7 [Q56UN5-4] A0A590UJK1 ENST00000358371.9 [Q56UN5-3] ENST00000656750.1 ENST00000662522.1 ENST00000375844.7 [Q56UN5-5] ENST00000637841.1 ENST00000392915.7 [Q56UN5-1] C9JGQ2 ENST00000375845.8 [Q56UN5-1] A0A1B0GTF4 |